Inventor

SANDERS STEVEN W

US11 patents

⚠️ This page may combine multiple inventors who share the name “SANDERS STEVEN W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WATSON LAB INC

6 patents

US7087241B2Aug 8, 2006

Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy

WATSON LAB INC25 citations92

US7029694B2Apr 18, 2006

Compositions and methods for transdermal oxybutynin therapy

WATSON LAB INC15 citations83

US7081251B2Jul 25, 2006

Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy

WATSON LAB INC8 citations73

US7081252B2Jul 25, 2006

Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy

WATSON LAB INC8 citations73

US7081249B2Jul 25, 2006

Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy

WATSON LAB INC9 citations73

US7081250B2Jul 25, 2006

Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy

WATSON LAB INC8 citations73

WATSON PHARMACEUTICALS INC

2 patents

US6743441B2Jun 1, 2004

Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy

WATSON PHARMACEUTICALS INC42 citations95

US7179483B2Feb 20, 2007

Compositions and methods for transdermal oxybutynin therapy

WATSON PHARMACEUTICALS INC11 citations83

EBERT CHARLES D

1 patent

US8241662B2Aug 14, 2012

Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy

EBERT CHARLES D2 citations56

SANDERS STEVEN W

1 patent

USD994832SAug 8, 2023

Hunting tool

SANDERS STEVEN W1 citations55

ALLERGAN SALES LLC

1 patent

US10272061B2Apr 30, 2019

Compositions and methods for unoccluded transdermal oxybutynin therapy

ALLERGAN SALES LLC0 citations51